Neurology Neuroimmunology & Neuroinflammation, 2025
FCRL5, a B-Cell Marker With Novel Diagnostic and Prognostic Value for Multiple Sclerosis

Deltombe M., Stölting A., Maggi P. et al.

Nature Communications, 2025
High expression of Rex-orf-I and HBZ mRNAs and bronchiectasis in lung of HTLV-1A/C infected macaques

Sarkis S., Gutowska A., Rahman M. et al.

RMD Open, 2025
Decreased GPR55 expression links B-cell activation and vascular remodelling in atherosclerosis in patients with early rheumatoid arthritis

Miranda-Prieto D., Alperi-López M., Pérez-Álvarez ?. et al.

Cardiovascular Research, 2025
Precision medicine requires precision proteomics: discordance between proteomic and clinical assays in UK Biobank

Singh B., Tzoulaki I., Mayr M.

Clinical and Translational Medicine, 2025
Multitemporal single‐cell profiling uncovers alveolar IL1β^hi neutrophils: A significant indicator of CARDS progression

Yang Y., Li H., Liu P. et al.

Signal Transduction and Targeted Therapy, 2025
Liquid biomarkers associate with TGF-β Type I receptor and hypoxia in kidney cancer

Mallikarjuna P., Erdem C., Beorlegui R. et al.

American Journal of Respiratory and Critical Care Medicine, 2025
ARDS Molecular Phenotypes Have Distinct Lower Respiratory Tract Transcriptomes

Sarma A., Christenson S., Zha B. et al.

PLOS Computational Biology, 2025
Exploration of potential novel drug targets for rheumatoid arthritis by plasma proteome screening

Ma Z., Chen R., Feng Z.

Inflammatory Bowel Diseases, 2025
Genome-Wide Aggregated Trans-Effects Analysis Implicates Deficient Type III Interferon Signaling as a Key Cause of Inflammatory Bowel Disease

McKeigue P., Iakovliev A., Erabadda B. et al.

Communications Chemistry, 2025
Current landscape of plasma proteomics from technical innovations to biological insights and biomarker discovery

Kirsher D., Chand S., Phong A. et al.

Psychoneuroendocrinology, 2025
Relationships between childhood adversity, resilience, and inflammatory profiles in Taiwanese young adults

Jaimes M., Chaimano S., Lin S. et al.

Cancer Letters, 2025
An anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) and chemotherapy for RAS/BRAF wild-type metastatic colorectal cancer: A phase Ib study

Bai M., Li N., Yin X. et al.

Science Translational Medicine, 2025
Progression to rheumatoid arthritis in at-risk individuals is defined by systemic inflammation and by T and B cell dysregulation

He Z., Glass M., Venkatesan P. et al.

Nature Communications, 2025
Shared genetic architecture contributes to risk of major cardiovascular diseases

Qiao J., Jiang L., Cai L. et al.

JAMA Dermatology, 2025
Mediterranean Diet and Patients With Psoriasis

Perez-Bootello J., Berna-Rico E., Abbad-Jaime de Aragon C. et al.

Discover Oncology, 2025
Causal effects of circulating inflammatory proteins on colorectal cancer: a Mendelian randomization and Spatial transcriptomic study

Bai M., Wu B., Li J. et al.

Movement Disorders Clinical Practice, 2025
High Cerebrospinal DOPA Decarboxylase Level Predicts Cognitive Decline in Parkinson's Disease

Sturchio A., Paslawski W., Khosousi S. et al.

International Journal of Molecular Sciences, 2025
Neuroprotective Effects of Vesatolimod in EAE: Modulating Immune Balance and Microglial Polarization

Chen X., Zhang J., Mu S.

Circulation: Heart Failure, 2025
Transpulmonary Proteome Gradients Identify Pathways Involved in Pulmonary Vascular Disease Due To Heart Failure

Melenovsky V., Jarolim P., Kutilkova E. et al.

JHEP Reports, 2025
PD-L1 and the risk of bacterial infection in patients with chronic liver diseases. An international multicohort study.

Juanola A., Mezzano G., Pose E. et al.